Answers are grounded in this paper and cite their sources.
Investigation reveals new psychiatric treatments in various populations, suggesting promising implications for mental health care.
Excitement has built recently about new avenues for psychiatric treatment: psychedelic drugs such as Ketamine and psilocybin; trans‐cranial magnetic stimulation (TMS). We see the revival of older practices such as electro‐convulsive shock therapy (ECT) and therapeutic lesioning, and medicines borrowed from other fields, like GLP‐1s.
No takes yet. Share an insight, caveat, or question.
David P. Lichtenstein (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: